Geode Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,999
| Closed | -$56.3K | – | 4543 |
|
|
2024
Q3 | $56.3K | Buy |
27,999
+6,201
| +28% | +$12.2K | ﹤0.01% | 4241 |
|
|
2024
Q2 | $36.2K | Buy |
21,798
+4,455
| +26% | +$11.7K | ﹤0.01% | 4345 |
|
|
2024
Q1 | $107K | Buy |
17,343
+1,623
| +10% | +$10.6K | ﹤0.01% | 4141 |
|
|
2023
Q4 | $110K | Buy |
15,720
+5,574
| +55% | +$43.3K | ﹤0.01% | 4155 |
|
|
2023
Q3 | $88.8K | Buy |
10,146
+2,631
| +35% | +$24.7K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $88.3K | Hold |
7,515
| – | – | ﹤0.01% | 4375 |
|
|
2023
Q1 | $129K | Hold |
7,515
| – | – | ﹤0.01% | 4244 |
|
|
2022
Q4 | $197K | Sell |
7,515
-18
| -0.2% | -$854 | ﹤0.01% | 4116 |
|
|
2022
Q3 | $764K | Buy |
7,533
+120
| +2% | +$16.2K | ﹤0.01% | 3529 |
|
|
2022
Q2 | $1.05M | Hold |
7,413
| – | – | ﹤0.01% | 3400 |
|
|
2022
Q1 | $1.17M | Buy |
7,413
+374
| +5% | +$60.4K | ﹤0.01% | 3540 |
|
|
2021
Q4 | $1.56M | Buy |
7,039
+2,051
| +41% | +$397K | ﹤0.01% | 3500 |
|
|
2021
Q3 | $962K | Buy |
4,988
+96
| +2% | +$20.4K | ﹤0.01% | 3695 |
|
|
2021
Q2 | $1.18M | Buy |
4,892
+616
| +14% | +$169K | ﹤0.01% | 3512 |
|
|
2021
Q1 | $1.45M | Buy |
4,276
+453
| +12% | +$184K | ﹤0.01% | 3409 |
|
|
2020
Q4 | $1.37M | Buy |
3,823
+731
| +24% | +$281K | ﹤0.01% | 3263 |
|
|
2020
Q3 | $1.43M | Buy |
+3,092
| New | +$873K | ﹤0.01% | 3062 |
|
Other funds holding TFFP
Geode Capital Management's TFFP Position: Q4 2024 in Review
Geode Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 27,999 shares — an estimated $56.3K sold.
Geode Capital Management first reported a position in TFFP in Q3 2020 and held it in 17 quarters. The position peaked at $1.56M in Q4 2021. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- Geode Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Geode Capital Management sold 27,999 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $56.3K.
- Geode Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 17 quarters.
- Geode Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.56M in Q4 2021.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.